Advertisement

Topics

Astellas Pharma Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

21:28 EDT 2 Sep 2017 | BioPortfolio Reports

Astellas Pharma Inc. Strategy, SWOT and Corporate Finance Report

Summary

Astellas Pharma Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Astellas Pharma Astellas or 'the company' is engaged in the manufacture, marketing, import and export of pharmaceuticals and related products. The company operates in Japan, Asia, the Americas, Europe, Middle East, and Africa EMEA and Oceania. It is headquartered in Tokyo, Japan and employed 17,217 people as of March 31, 2016.

Scope

Detailed information on Astellas Pharma Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis
An indepth view of the business model of Astellas Pharma Inc. including a breakdown and examination of key business segments
Intelligence on Astellas Pharma Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Astellas Pharma Inc., such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Astellas Pharma Inc. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Astellas Pharma Inc. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Astellas Pharma Inc.'s business structure, strategy and prospects.

Original Article: Astellas Pharma Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Astellas Pharma Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175"

Quick Search
Advertisement
 

Relevant Topic

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.